Video Experimental Relacionado
Updated: Jun 16, 2026
08:48
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
3.2K
El perfil inmune profundo de los pacientes con COVID-19 revela distintos inmunotipos con implicaciones terapéuticas
Divij Mathew1,2, Josephine R Giles1,2,3, Amy E Baxter1,2
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Science (New York, N.Y.)
|July 17, 2020
Resumen
Las respuestas inmunológicas humanas al COVID-19 son complejas. Este estudio identificó tres inmunotipos distintos en pacientes con enfermedad por coronavirus 2019, ofreciendo información para el desarrollo de terapias y vacunas dirigidas.
Área de la Ciencia:
- Inmunología
- Virología
- Enfermedades infecciosas
Sus antecedentes:
- La respuesta inmune humana al coronavirus 2 del síndrome respiratorio agudo severo (SARS-CoV-2) no se entiende completamente, a pesar de la pandemia de COVID-19 en curso.
- La caracterización de la dinámica celular inmune es crucial para comprender la progresión de la enfermedad y desarrollar intervenciones efectivas.
Objetivo del estudio:
- Para investigar la heterogeneidad de las respuestas inmunes en pacientes con COVID-19.
- Identificar perfiles inmunológicos distintos (inmunotipos) asociados con la gravedad y los resultados de la enfermedad.
- Explorar las implicaciones de estos inmunotipos para el desarrollo terapéutico y de vacunas.
Principales métodos:
- Utilizó citometría de alta dimensión para analizar las poblaciones de células inmunes en 125 pacientes con COVID-19, comparándolas con individuos recuperados y sanos.
- Análisis integrado de aproximadamente 200 características inmunológicas y 50 parámetros clínicos.
- Se identificaron firmas inmunológicas estables y dinámicas correlacionadas con las trayectorias de gravedad de la enfermedad.
Principales resultados:
- Una proporción de pacientes con COVID-19 exhibieron subconjuntos de células T y B activados, y algunos mostraron activación de células T típica de la infección viral aguda y respuestas plasmablast significativas.
- Otro subgrupo mostró niveles de activación de linfocitos comparables a los de los individuos no infectados.
- Se identificaron tres inmunotipos distintos, correlacionados con malas trayectorias clínicas frente a la mejora de la salud.
Conclusiones:
- Las respuestas inmunológicas de los pacientes con COVID-19 son heterogéneas, con distintos tipos inmunológicos identificados.
- Estos inmunotipos están relacionados con la gravedad de la enfermedad y los resultados clínicos.
- Comprender estas firmas inmunológicas puede informar el diseño de terapias y vacunas dirigidas contra el COVID-19.
Videos de Conceptos Relacionados
01:36Humoral Immune Responses
Overview
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:23Immunological Memory
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...